Abstract
Abnormal glutamate metabolism is implied in the pathogenesis of Amyotrophic Lateral Sclerosis (ALS) and cerebrospinal fluid (CSF) glutamate levels appear to be elevated. Since nitric oxide (NO) inhibits glutamate transport, excessive amounts of nitrie oxide could underlie the glutamate induced neurotoxicity in ALS. Stable metabolites of NO (NO−2 + NO−3) levels were determined in serum and CSF of sporadic ALS patients and control subjects. NO−2 + NO−3 levels were higher in ALS, in males and in serum samples compared to controls, females and CSF, respectively. Furthermore, while the difference between serum and CSF NO−2 + NO−3 levels was significant in males (higher in serum) no such difference was observed in females. Our results suggest that nitrie oxide may be involved in the pathogenesis of ALS directly or indirectly and in a sexually dimorphic manner.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.